STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.

Publication

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.

Journal Paper/Review - Aug 12, 2023

Woelfel Simon, Dütschler Joel, König Marius, Dulovic Alex, Graf Nicole, Junker Daniel, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Koller Seraina, Wyss Jacqueline, Krupka Niklas, Oberholzer Melanie, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Albrich Werner, Friedrich Matthias, Schneiderhan-Marra Nicole, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan

Woelfel, Simon

Dütschler, Joel

attending physician
Gastroenterology/Hepatology · Dept. I

König, Marius

resident physician
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin, Gastroenterology/Hepatology · Dept. I

Dulovic, Alex

Graf, Nicole

Medizinisches Forschungszentrum, Clinical Trials Unit · Management

Junker, Daniel

Oikonomou, Vasileios

Forsch, Kristina

Koller, Seraina

Wyss, Jacqueline

Krupka, Niklas

Oberholzer, Melanie

Frei, Nicola Fabian

attending physician
Gastroenterology/Hepatology · Dept. I